Title: John Mao - Innovator in Pharmaceutical Compositions
Introduction
John Mao is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceutical compositions, particularly in enhancing the solubility and bioavailability of certain compounds. His work is aimed at improving treatment options for various diseases.
Latest Patents
John Mao holds a patent for "Compositions Comprising Inhibitors of Macrophage Elastase and Cyclodextrin." This invention provides formulations that combine a specific compound, 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione, with cyclodextrin and other excipients. The formulations are designed to increase the water solubility and oral bioavailability of the compound, which may be beneficial in treating diseases such as asthma through the inhibition of matrix metalloproteinase -12.
Career Highlights
John Mao is currently employed at Foresee Pharmaceuticals, LLC, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new formulations that can lead to more effective treatments for patients.
Collaborations
John collaborates with Chiating Huang, contributing to the advancement of their shared goals in pharmaceutical research and development.
Conclusion
John Mao is a notable inventor whose work in pharmaceutical compositions has the potential to significantly impact treatment methodologies. His innovative approach to enhancing drug solubility and bioavailability showcases his commitment to improving healthcare solutions.